Immune cell activity during the initial stages of withdrawal from chronic exposure to cocaine or morphine

Journal of Neuroimmunology

Volumn 147, Issue 1-2, 2004, Pages 109-113

  Avila, Albert H ^a   Alonzo, Norma C ^a   Bayer, Barbara M ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cocaine; Immune system; Lymphocyte proliferation; Morphine; Stress

Indexed keywords

COCAINE; CONCANAVALIN A; CORTICOSTERONE; MITOGENIC AGENT; MORPHINE; NARCOTIC AGENT; THYMIDINE; TRITIUM;

ANALYSIS OF VARIANCE; ANIMAL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; BLOOD; COCAINE DEPENDENCE; COMPARATIVE STUDY; CONFERENCE PAPER; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG WITHDRAWAL; EXPERIMENTAL MODEL; IMMUNOLOGY; INFECTION SENSITIVITY; LONG TERM EXPOSURE; LYMPHOCYTE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; MALE; MORPHINE ADDICTION; NONHUMAN; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; RAT; RAT STRAIN; SPECIES COMPARISON; STRESS; TIME; WITHDRAWAL SYNDROME;

EID: 1642575040     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2003.10.023     Document Type: Conference Paper

References (28)

1. Baumann M.H., Gendron T.M., Becketts K.M., Henningeld J.E., Gorelick D.A., Rothman R.B. Effects of intravenous cocaine on plasma cortisol and prolactin in human cocaine abusers. Biol. Psychiatry. 38:1995;751-755.
2. Bayer B.M., Hernandez M.C., Ding X.Z. Tolerance and cross tolerance to the suppressive effects of cocaine and morphine on lymphocyte proliferation. Br. Behav. Immun. 53:1996;227-234.
3. Berke J.D., Hyman S.E. Addiction, dopamine, and molecular mechanisms of memory. Neuron. 25(3):2000;515-532.
4. Borowsky B., Kuhn C.M. Chronic cocaine administration sensitizes behavioral but not neuroendocrine responses. Brain Res. 543:1991;301-306.
5. Buckingham J.C., Cooper T.A. Differences in hypothalamo-pituitary- adrenocortical activity in the rat after acute and prolonged treatment with morphine. Neuroendocrinology. 38:1984;411-417.
6. Devoto P., Flore G., Pira L., Gessa L. Co-release of noradrenaline and dopamine in the prefrontal cortex after acute morphine and during morphine withdrawal. Psychopharmacology (Berl.). 160:2002;220-224.
7. Fuentealba J.A., Forray M.I., Gysling K. Chronic morphine treatment and withdrawal increase extracellular levels of norepinephrine in the rat bed nucleus of the stria terminalis. J. Neurochem. 75:2000;741-748.
8. Goeders N.E. The HPA axis and cocaine reinforcement. Psychoneuroendocrinology. 27:2002;13-33.
9. Gonzalez S., Fernandez-Ruiz J., Sparpaglione V., Parolaro D., Ramos J.A. Chronic exposure to morphine, cocaine or ethanol in rats produced different effects in brain cannabinoid CB(1) receptor binding and mRNA levels. Drug Alcohol Depend. 66:2002;77-84.
10. Houshyar H., Galigniana M.D., Prat W.B., Woods J.H. Differential responsivity of the hypothalamic-pituitary-adrenal axis to glucocorticoid negative-feedback and corticotropin releasing hormone in rats undergoing morphine withdrawal: possible mechanisms involved in facilitated and attenuated stress responses. J. Neuroendocrinol. 13:2001;875-886.
11. Kishioka S., Nishida S., Fukunaga Y., Yamamoto H. Quantitative properties of plasma corticosterone elevation induced by naloxone-precipitated withdrawal in morphine-dependent rats. Jpn. J. Pharmacol. 66:1994;257-263.
12. Klein T.W., Newton C., Friedman H. Cocaine effects on cultured lymphocytes. Adv. Exp. Med. Biol. 288:1991;151-158.
13. Koob G.F. Stress, corticotropin-releasing factor and drug addiction. Ann. N.Y. Acad. Sci. 987:1999;27-45.
14. Kuhar M.J., Pilotte N.S. Neurochemical changes in cocaine withdrawal. Trends Pharmacol. Sci. 17:1996;260-264.
15. Martinez-Pinero M.G., Milanes M.V., Alcaraz C., Vargas M.L. Catecholaminergic mediation of morphine-induced activation of pituitary-adrenocortical axis in the rat: implication of alpha- and beta- adrenoceptors. Brain Res. 668:1994;122-128.
16. Mellon R.D., Bayer B.M. The effects of morphine, nicotine and epibatidine on lymphocyte activity and hypothalamic-pituitary-adrenal axis responses. J. Pharmacol. Exp. Ther. 288:1999;635-642.
17. Mendelson J.H., Teoh S.K., Mello N.K., Ellingboe J., Rhodes E. Acute effects of cocaine on plasma ACTH, luteinizing hormone and prolactin levels in cocaine-dependent men. J. Pharmacol. Exp. Ther. 270:1992;1134-1138.
18. Parrillo J.E., Fauci A.S. Mechanisms of glucocorticoid action on immune processes. Ann. Rev. Pharmacol. Toxicol. 19:1979;179-201.
19. Pellegrino T., Bayer B.M. In vivo effects of cocaine on immune cell function. J. Neuroimmunol. 83:1998;139-147.
20. Piazza P.V., Le Moal M. The role of stress in drug self-administration. Trends Pharmacol. Sci. 19:1998;67-74.
21. Richter R.M., Weiss F. In vivo CRF release in rat amygdala is increased during cocaine withdrawal in self-administering rats. Synapse. 32:1999;254-261.
22. Rivier C., Vale W. Cocaine stimulates adrenocorticotropin (ACTH) secretion through a corticotropin-releasing factor (CRF)-mediated mechanism. Brain Res. 422:1987;403-406.
23. Sarnyai Z., Biro E., Penke B., Telegdy G. The cocaine-induced elevation of plasma corticosterone is mediated by endogenous corticotropin-releasing factor (CRF) in rats. Brain Res. 589:1992;154-156.
24. Sarnyai Z., Mello N.K., Mendelson J.H., Eros-Sarnyai M., Mercer G. Effects of cocaine on pulsatile activity of the hypothalamic-pituitary-adrenal axis in male rhesus monkeys: neuroendocrine and behavioral correlates. J. Pharmacol. Exp. Ther. 277:1996;225-234.
25. Self D.W., Nestler E.J. Molecular mechanisms of drug reinforcement and addiction. Annu. Rev. Neurosci. 18:1995;463-495.
26. Van Dyke C., Stesin A., Jones R., Chuntharapai A., Seaman W. Cocaine increases natural killer cell activity. J. Clin. Invest. 77:1986;1387-1390.
27. West J.P., Lysle D.T., Dykstra L.A. Tolerance development to morphine-induced alterations of immune status. Drug Alcohol Depend. 46:1997;147-157.
28. Zhu Y., King M.A., Schuller A.G., Nitsche J.F., Reidl M., Elde R.P., Unterwald E., Pasternak G.W., Pintar J.E. Retention of supraspinal delta-like analgesia and loss of morphine tolerance in delta opioid receptor knockout mice. Neuron. 24:1999;243-252.